(Q40173621)

English

Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention

scientific article published on March 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Signaling mechanisms of melatonin in antiproliferation of hormone-refractory 22Rv1 human prostate cancer cells: implications for prostate cancer chemoprevention (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Chun W Tam

1

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Chi W Mo

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Kwok-Ming Yao

3

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Stephen Y W Shiu

4

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

191-202

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Androgen deprivation therapy for prostate cancer: current status and future prospects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

The melatonin rhythm: both a clock and a calendar

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Light pollution, melatonin suppression and cancer growth.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Reduced cancer incidence among the blind

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Human melatonin production decreases with age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Aging and the circadian rhythm of melatonin: a cross-sectional study of Chinese subjects 30-110 yr of age.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Hormonal interactions in human prostate tumor LNCaP cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin slowed the early biochemical progression of hormone-refractory prostate cancer in a patient whose prostate tumor tissue expressed MT1 receptor subtype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin receptors step into the light: cloning and classification of subtypes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

A role for GATA transcription factors in the androgen regulation of the prostate-specific antigen gene enhancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Understanding p27(kip1) deregulation in cancer: down-regulation or mislocalization

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Transition to androgen-independence in prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin and mammary cancer: a short review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

The murine gene p27Kip1 is haplo-insufficient for tumour suppression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin as a radioprotective agent: a review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

The progression of LNCaP human prostate cancer cells to androgen independence involves decreased FOXO3a expression and reduced p27KIP1 promoter transactivation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Evaluation of signal transduction pathways mediating the nuclear exclusion of the androgen receptor by melatonin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Melatonin madness.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.2006.00406.X

21 January 2018

Identifiers

10.1111/J.1600-079X.2006.00406.X

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40173621&oldid=1888275043"